ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global VHH Antibody Drugs Market Research Report 2024
Published Date: June 2024
|
Report Code: QYRE-Auto-32A17407
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global VHH Antibody Drugs Market Research Report 2024
BUY CHAPTERS

Global VHH Antibody Drugs Market Research Report 2024

Code: QYRE-Auto-32A17407
Report
June 2024
Pages:73
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Janssen Pharmaceuticals
Sanofi
Sanofi S A
Sanofi Company(Ablynx)
ALPHAMAB ONCOLOGY
Legend Biotech

VHH Antibody Drugs Market

Nanobody (Nb), also known as VHH (Variable domain of heavy chain of HCAb) antibody or single-domain antibody, is a small antibody molecule. Compared with traditional antibodies, VHH has smaller molecular size, higher stability and easier engineering, and has a wide range of biomedical application potential.
The global VHH Antibody Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for VHH Antibody Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for VHH Antibody Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of VHH Antibody Drugs include Janssen Pharmaceuticals, Sanofi Company(Ablynx), Alphamab Oncology, Legend Biotech, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for VHH Antibody Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding VHH Antibody Drugs.
The VHH Antibody Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global VHH Antibody Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the VHH Antibody Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of VHH Antibody Drugs Market Report

Report Metric Details
Report Name VHH Antibody Drugs Market
Segment by Type
  • Monovalent Nanobody
  • Bivalent Nanobody
  • Bispecific Nanobody
  • Others
Segment by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Janssen Pharmaceuticals, Sanofi Company(Ablynx), Alphamab Oncology, Legend Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of VHH Antibody Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of VHH Antibody Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the VHH Antibody Drugs Market report?

Ans: The main players in the VHH Antibody Drugs Market are Janssen Pharmaceuticals, Sanofi Company(Ablynx), Alphamab Oncology, Legend Biotech

What are the Application segmentation covered in the VHH Antibody Drugs Market report?

Ans: The Applications covered in the VHH Antibody Drugs Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the VHH Antibody Drugs Market report?

Ans: The Types covered in the VHH Antibody Drugs Market report are Monovalent Nanobody, Bivalent Nanobody, Bispecific Nanobody, Others

1 VHH Antibody Drugs Market Overview
1.1 Product Definition
1.2 VHH Antibody Drugs by Type
1.2.1 Global VHH Antibody Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Monovalent Nanobody
1.2.3 Bivalent Nanobody
1.2.4 Bispecific Nanobody
1.2.5 Others
1.3 VHH Antibody Drugs by Application
1.3.1 Global VHH Antibody Drugs Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global VHH Antibody Drugs Market Size Estimates and Forecasts
1.4.1 Global VHH Antibody Drugs Revenue 2019-2030
1.4.2 Global VHH Antibody Drugs Sales 2019-2030
1.4.3 Global VHH Antibody Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 VHH Antibody Drugs Market Competition by Manufacturers
2.1 Global VHH Antibody Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global VHH Antibody Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global VHH Antibody Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of VHH Antibody Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of VHH Antibody Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of VHH Antibody Drugs, Product Type & Application
2.7 Global Key Manufacturers of VHH Antibody Drugs, Date of Enter into This Industry
2.8 Global VHH Antibody Drugs Market Competitive Situation and Trends
2.8.1 Global VHH Antibody Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest VHH Antibody Drugs Players Market Share by Revenue
2.8.3 Global VHH Antibody Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global VHH Antibody Drugs Market Scenario by Region
3.1 Global VHH Antibody Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global VHH Antibody Drugs Sales by Region: 2019-2030
3.2.1 Global VHH Antibody Drugs Sales by Region: 2019-2024
3.2.2 Global VHH Antibody Drugs Sales by Region: 2025-2030
3.3 Global VHH Antibody Drugs Revenue by Region: 2019-2030
3.3.1 Global VHH Antibody Drugs Revenue by Region: 2019-2024
3.3.2 Global VHH Antibody Drugs Revenue by Region: 2025-2030
3.4 North America VHH Antibody Drugs Market Facts & Figures by Country
3.4.1 North America VHH Antibody Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America VHH Antibody Drugs Sales by Country (2019-2030)
3.4.3 North America VHH Antibody Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe VHH Antibody Drugs Market Facts & Figures by Country
3.5.1 Europe VHH Antibody Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe VHH Antibody Drugs Sales by Country (2019-2030)
3.5.3 Europe VHH Antibody Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific VHH Antibody Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific VHH Antibody Drugs Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific VHH Antibody Drugs Sales by Region (2019-2030)
3.6.3 Asia Pacific VHH Antibody Drugs Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America VHH Antibody Drugs Market Facts & Figures by Country
3.7.1 Latin America VHH Antibody Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America VHH Antibody Drugs Sales by Country (2019-2030)
3.7.3 Latin America VHH Antibody Drugs Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa VHH Antibody Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa VHH Antibody Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa VHH Antibody Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa VHH Antibody Drugs Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global VHH Antibody Drugs Sales by Type (2019-2030)
4.1.1 Global VHH Antibody Drugs Sales by Type (2019-2024)
4.1.2 Global VHH Antibody Drugs Sales by Type (2025-2030)
4.1.3 Global VHH Antibody Drugs Sales Market Share by Type (2019-2030)
4.2 Global VHH Antibody Drugs Revenue by Type (2019-2030)
4.2.1 Global VHH Antibody Drugs Revenue by Type (2019-2024)
4.2.2 Global VHH Antibody Drugs Revenue by Type (2025-2030)
4.2.3 Global VHH Antibody Drugs Revenue Market Share by Type (2019-2030)
4.3 Global VHH Antibody Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global VHH Antibody Drugs Sales by Application (2019-2030)
5.1.1 Global VHH Antibody Drugs Sales by Application (2019-2024)
5.1.2 Global VHH Antibody Drugs Sales by Application (2025-2030)
5.1.3 Global VHH Antibody Drugs Sales Market Share by Application (2019-2030)
5.2 Global VHH Antibody Drugs Revenue by Application (2019-2030)
5.2.1 Global VHH Antibody Drugs Revenue by Application (2019-2024)
5.2.2 Global VHH Antibody Drugs Revenue by Application (2025-2030)
5.2.3 Global VHH Antibody Drugs Revenue Market Share by Application (2019-2030)
5.3 Global VHH Antibody Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Janssen Pharmaceuticals
6.1.1 Janssen Pharmaceuticals Company Information
6.1.2 Janssen Pharmaceuticals Description and Business Overview
6.1.3 Janssen Pharmaceuticals VHH Antibody Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Janssen Pharmaceuticals VHH Antibody Drugs Product Portfolio
6.1.5 Janssen Pharmaceuticals Recent Developments/Updates
6.2 Sanofi Company(Ablynx)
6.2.1 Sanofi Company(Ablynx) Company Information
6.2.2 Sanofi Company(Ablynx) Description and Business Overview
6.2.3 Sanofi Company(Ablynx) VHH Antibody Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Company(Ablynx) VHH Antibody Drugs Product Portfolio
6.2.5 Sanofi Company(Ablynx) Recent Developments/Updates
6.3 Alphamab Oncology
6.3.1 Alphamab Oncology Company Information
6.3.2 Alphamab Oncology Description and Business Overview
6.3.3 Alphamab Oncology VHH Antibody Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Alphamab Oncology VHH Antibody Drugs Product Portfolio
6.3.5 Alphamab Oncology Recent Developments/Updates
6.4 Legend Biotech
6.4.1 Legend Biotech Company Information
6.4.2 Legend Biotech Description and Business Overview
6.4.3 Legend Biotech VHH Antibody Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Legend Biotech VHH Antibody Drugs Product Portfolio
6.4.5 Legend Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 VHH Antibody Drugs Industry Chain Analysis
7.2 VHH Antibody Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 VHH Antibody Drugs Production Mode & Process
7.4 VHH Antibody Drugs Sales and Marketing
7.4.1 VHH Antibody Drugs Sales Channels
7.4.2 VHH Antibody Drugs Distributors
7.5 VHH Antibody Drugs Customers
8 VHH Antibody Drugs Market Dynamics
8.1 VHH Antibody Drugs Industry Trends
8.2 VHH Antibody Drugs Market Drivers
8.3 VHH Antibody Drugs Market Challenges
8.4 VHH Antibody Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Janssen Pharmaceuticals
Sanofi
Sanofi S A
Sanofi Company(Ablynx)
ALPHAMAB ONCOLOGY
Legend Biotech
List of Tables
 Table 1. Global VHH Antibody Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global VHH Antibody Drugs Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global VHH Antibody Drugs Market Competitive Situation by Manufacturers in 2023
 Table 4. Global VHH Antibody Drugs Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global VHH Antibody Drugs Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global VHH Antibody Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global VHH Antibody Drugs Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market VHH Antibody Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of VHH Antibody Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of VHH Antibody Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of VHH Antibody Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of VHH Antibody Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global VHH Antibody Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in VHH Antibody Drugs as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global VHH Antibody Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global VHH Antibody Drugs Sales by Region (2019-2024) & (K Units)
 Table 18. Global VHH Antibody Drugs Sales Market Share by Region (2019-2024)
 Table 19. Global VHH Antibody Drugs Sales by Region (2025-2030) & (K Units)
 Table 20. Global VHH Antibody Drugs Sales Market Share by Region (2025-2030)
 Table 21. Global VHH Antibody Drugs Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global VHH Antibody Drugs Revenue Market Share by Region (2019-2024)
 Table 23. Global VHH Antibody Drugs Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global VHH Antibody Drugs Revenue Market Share by Region (2025-2030)
 Table 25. North America VHH Antibody Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America VHH Antibody Drugs Sales by Country (2019-2024) & (K Units)
 Table 27. North America VHH Antibody Drugs Sales by Country (2025-2030) & (K Units)
 Table 28. North America VHH Antibody Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America VHH Antibody Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe VHH Antibody Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe VHH Antibody Drugs Sales by Country (2019-2024) & (K Units)
 Table 32. Europe VHH Antibody Drugs Sales by Country (2025-2030) & (K Units)
 Table 33. Europe VHH Antibody Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe VHH Antibody Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific VHH Antibody Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific VHH Antibody Drugs Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific VHH Antibody Drugs Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific VHH Antibody Drugs Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific VHH Antibody Drugs Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America VHH Antibody Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America VHH Antibody Drugs Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America VHH Antibody Drugs Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America VHH Antibody Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America VHH Antibody Drugs Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa VHH Antibody Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa VHH Antibody Drugs Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa VHH Antibody Drugs Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa VHH Antibody Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa VHH Antibody Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global VHH Antibody Drugs Sales (K Units) by Type (2019-2024)
 Table 51. Global VHH Antibody Drugs Sales (K Units) by Type (2025-2030)
 Table 52. Global VHH Antibody Drugs Sales Market Share by Type (2019-2024)
 Table 53. Global VHH Antibody Drugs Sales Market Share by Type (2025-2030)
 Table 54. Global VHH Antibody Drugs Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global VHH Antibody Drugs Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global VHH Antibody Drugs Revenue Market Share by Type (2019-2024)
 Table 57. Global VHH Antibody Drugs Revenue Market Share by Type (2025-2030)
 Table 58. Global VHH Antibody Drugs Price (US$/Unit) by Type (2019-2024)
 Table 59. Global VHH Antibody Drugs Price (US$/Unit) by Type (2025-2030)
 Table 60. Global VHH Antibody Drugs Sales (K Units) by Application (2019-2024)
 Table 61. Global VHH Antibody Drugs Sales (K Units) by Application (2025-2030)
 Table 62. Global VHH Antibody Drugs Sales Market Share by Application (2019-2024)
 Table 63. Global VHH Antibody Drugs Sales Market Share by Application (2025-2030)
 Table 64. Global VHH Antibody Drugs Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global VHH Antibody Drugs Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global VHH Antibody Drugs Revenue Market Share by Application (2019-2024)
 Table 67. Global VHH Antibody Drugs Revenue Market Share by Application (2025-2030)
 Table 68. Global VHH Antibody Drugs Price (US$/Unit) by Application (2019-2024)
 Table 69. Global VHH Antibody Drugs Price (US$/Unit) by Application (2025-2030)
 Table 70. Janssen Pharmaceuticals Company Information
 Table 71. Janssen Pharmaceuticals Description and Business Overview
 Table 72. Janssen Pharmaceuticals VHH Antibody Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Janssen Pharmaceuticals VHH Antibody Drugs Product
 Table 74. Janssen Pharmaceuticals Recent Developments/Updates
 Table 75. Sanofi Company(Ablynx) Company Information
 Table 76. Sanofi Company(Ablynx) Description and Business Overview
 Table 77. Sanofi Company(Ablynx) VHH Antibody Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Sanofi Company(Ablynx) VHH Antibody Drugs Product
 Table 79. Sanofi Company(Ablynx) Recent Developments/Updates
 Table 80. Alphamab Oncology Company Information
 Table 81. Alphamab Oncology Description and Business Overview
 Table 82. Alphamab Oncology VHH Antibody Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Alphamab Oncology VHH Antibody Drugs Product
 Table 84. Alphamab Oncology Recent Developments/Updates
 Table 85. Legend Biotech Company Information
 Table 86. Legend Biotech Description and Business Overview
 Table 87. Legend Biotech VHH Antibody Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Legend Biotech VHH Antibody Drugs Product
 Table 89. Legend Biotech Recent Developments/Updates
 Table 90. Key Raw Materials Lists
 Table 91. Raw Materials Key Suppliers Lists
 Table 92. VHH Antibody Drugs Distributors List
 Table 93. VHH Antibody Drugs Customers List
 Table 94. VHH Antibody Drugs Market Trends
 Table 95. VHH Antibody Drugs Market Drivers
 Table 96. VHH Antibody Drugs Market Challenges
 Table 97. VHH Antibody Drugs Market Restraints
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Product Picture of VHH Antibody Drugs
 Figure 2. Global VHH Antibody Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global VHH Antibody Drugs Market Share by Type: 2023 & 2030
 Figure 4. Monovalent Nanobody Product Picture
 Figure 5. Bivalent Nanobody Product Picture
 Figure 6. Bispecific Nanobody Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global VHH Antibody Drugs Market Value by Application (2024-2030) & (US$ Million)
 Figure 9. Global VHH Antibody Drugs Market Share by Application: 2023 & 2030
 Figure 10. Hospital
 Figure 11. Clinic
 Figure 12. Other
 Figure 13. Global VHH Antibody Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 14. Global VHH Antibody Drugs Market Size (2019-2030) & (US$ Million)
 Figure 15. Global VHH Antibody Drugs Sales (2019-2030) & (K Units)
 Figure 16. Global VHH Antibody Drugs Average Price (US$/Unit) & (2019-2030)
 Figure 17. VHH Antibody Drugs Report Years Considered
 Figure 18. VHH Antibody Drugs Sales Share by Manufacturers in 2023
 Figure 19. Global VHH Antibody Drugs Revenue Share by Manufacturers in 2023
 Figure 20. Global 5 and 10 Largest VHH Antibody Drugs Players: Market Share by Revenue in VHH Antibody Drugs in 2023
 Figure 21. VHH Antibody Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 22. Global VHH Antibody Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 23. North America VHH Antibody Drugs Sales Market Share by Country (2019-2030)
 Figure 24. North America VHH Antibody Drugs Revenue Market Share by Country (2019-2030)
 Figure 25. United States VHH Antibody Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Canada VHH Antibody Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. Europe VHH Antibody Drugs Sales Market Share by Country (2019-2030)
 Figure 28. Europe VHH Antibody Drugs Revenue Market Share by Country (2019-2030)
 Figure 29. Germany VHH Antibody Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. France VHH Antibody Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. U.K. VHH Antibody Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Italy VHH Antibody Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Russia VHH Antibody Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Asia Pacific VHH Antibody Drugs Sales Market Share by Region (2019-2030)
 Figure 35. Asia Pacific VHH Antibody Drugs Revenue Market Share by Region (2019-2030)
 Figure 36. China VHH Antibody Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Japan VHH Antibody Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. South Korea VHH Antibody Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. India VHH Antibody Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Australia VHH Antibody Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. China Taiwan VHH Antibody Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Southeast Asia VHH Antibody Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Latin America VHH Antibody Drugs Sales Market Share by Country (2019-2030)
 Figure 44. Mexico VHH Antibody Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Brazil VHH Antibody Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Argentina VHH Antibody Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Colombia VHH Antibody Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Middle East and Africa VHH Antibody Drugs Sales Market Share by Country (2019-2030)
 Figure 49. Middle East and Africa VHH Antibody Drugs Revenue Market Share by Country (2019-2030)
 Figure 50. Turkey VHH Antibody Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Saudi Arabia VHH Antibody Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. UAE VHH Antibody Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 53. Global Sales Market Share of VHH Antibody Drugs by Type (2019-2030)
 Figure 54. Global Revenue Market Share of VHH Antibody Drugs by Type (2019-2030)
 Figure 55. Global VHH Antibody Drugs Price (US$/Unit) by Type (2019-2030)
 Figure 56. Global Sales Market Share of VHH Antibody Drugs by Application (2019-2030)
 Figure 57. Global Revenue Market Share of VHH Antibody Drugs by Application (2019-2030)
 Figure 58. Global VHH Antibody Drugs Price (US$/Unit) by Application (2019-2030)
 Figure 59. VHH Antibody Drugs Value Chain
 Figure 60. VHH Antibody Drugs Production Process
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Construction of VHH antibody library Market Research Report 2024
Global Nanobody Sequence Library Market Research Report 2024
Global VHH Nanobodies Market Research Report 2024
Global Single Domain Antibody sdAbs Drugs Market Research Report 2024
Global Single Domain Antibody Library Service Market Research Report 2024
Global Nanobody Discovery Service Market Research Report 2024
Global Single Domain Heavy Chain Antibody Market Research Report 2025
XDH Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Custom Nanobody Service Market Research Report 2025
Global Research Grade Antibodies Market Research Report 2024
NeuN Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Small Molecule Antibodies Market Insights Forecast to 2030
B220 Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
B7 H3 Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti Camelid VHH Antibody Market Research Report 2024
Vimentin Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti GFP Nanobody Market Research Report 2024
Global Nanobody Drug Market Research Report 2024
Global Myoglobin Antibody Market Research Report 2024
Global BAG1 Antibody Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions